Nuwacell Biotech’s NCR101 Approved for ILD Clinical Study by China’s CDE
According to the Center for Drug Evaluation (CDE) website, China-based Nuwacell Biotechnology Co., Ltd. has...
Nuwacell Biotechnology
Nuwacell Biotechnologies Secures RMB150 Million in Series B Financing for iPSC Therapies
Nuwacell Biotechnologies Co., Ltd., a specialist in induced pluripotent stem cell (iPSC) technology based in...